Lygos is an industrial biotechnology company developing a commercial bioprocess for manufacturing bio-based malonic acid. It was founded in 2010 by Eric Steen, Jay Keasling, and Jeffrey Dietrich in Berkeley, California.
Lygos received support from the United States Department of Energy (DOE) for their work on microbial fermentation technology to produce malonic acid. The bioprocess will lower the environmental impact and cost of manufacturing the specialty chemical compared to petroleum-based production processes.
Lygos received $120k in seed funding from Y combinator, FundersClub, Fifty Years, Brainchild Holdings, and 10xGroup.
The funding round led by IA Ventures and First Round Capital, along with Y Combinator Continuity Fund and OS Fund closed at $15.5 million dollars in July 2018.
Currently, no events have been added to this timeline yet.
Be the first one to add some.
Visolis, Lygos pick up support via DOE’s Small Business Vouchers Pilot Program, as DOE opens funding Round 2
Documentaries, videos and podcasts
No infobox has been created on this topic. Be the first to add one.